eniferBio is a Finnish biotechnology company specializing in the production of high-protein nutrition solutions. enifer’s production process leverages a special fermentation method that upcycles byproducts from various agricultural, food, and forestry processes.
The company's flagship product is PEKILO, a single-cell mycoprotein, consisting of up to 70% protein, along with beta-glucan, fibers, minerals, and fat. It is color- and taste-neutral and can be used in aquafeed, petfood, and alternative meat applications.
Key customers and partnerships
eniferBio has established significant partnerships within the feed and food industries. Notable collaborations include Skretting, Purina, and Valio.
Funding and financials
In its latest funding round in April 2023, eniferBio raised EUR 11 million (~USD 12.1 million) in Series A funding led by Aqua-Spark, with participation from Tesi, Valio, Voima Ventures, and Nordic Foodtech VC. The funds raised were earmarked for scaling up the production of PEKILO. Additionally, the company aims to obtain Novel Food approval from the EU and other markets to broaden its product's reach.
Further, the company received a EUR 12 million (~USD 13.2 million) grant from the NextGenerationEU program. The grant was to be used for building its mycoprotein factory in the Uusimaa region, capable of producing 3 million kilograms of PEKILO, annually.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.